SOCS1 mutations are rather common in DLBCL; in a patient cohort of 138 primary untreated DLBCL patients that we subjected to targeted high‐throughput sequencing of either all exons or the hotspots of 68 frequently mutated genes in B‐cell lymphomas, SOCS1 mutations emerged as the second most common mutation, affecting 28% of patients (Juskevicius et al, 2017). This evidence concerns the gene SOCS1 and diffuse large B-cell lymphoma.